- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06121817
Thermogenic Effect and Metabolic Responses of Durian
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Visit 1: Consenting and screening for study criteria. Visit 1 consists of consenting and screening session. Potential subjects will arrive at CNRC at 8h30 after 10-hour overnight fast (at least), only allowed access to water. A copy of written participant information sheet and informed consent form (ICF) will be given for them to read through carefully with needed time, and they may question for unclarity. Upon satisfaction, subjects must sign the ICF prior to the study procedures. After the consent, subjects will be screened for their eligibility with health screening questionnaire, and undergo anthropometric measurements (i.e. weight, height, waist circumference, and hip circumference). BMI will be calculated using formular weight divided by meter square (kg/m2). Blood pressure and heart rate readings will be taken. Body composition will be assessed using bioimpedance (BIA). Female subjects will be required to perform a β-HCG test using a urinary pregnancy test kit. Fasting glucose test will be performed through finger prick.
Visit 2 and 3: Intervention study (durian or banana will be assigned randomly) Visit 2 and visit 3 correspond to test session. Female subjects will be tested in the follicular phase of the menstrual cycle (the last menstrual cycle will be noted during screening and regular follow-up for the update). On each test day, subjects will arrive at CNRC at 8h30 after 10-hour overnight fast (at least), only water is allowed. They will undergo anthropometric measurements, and then instructed to lay comfortably on a bed in a suite (room temperature 22-24°C) for 45-minute of resting metabolic rate (RMR) measurement. Blood pressure, heart rate, fasting blood glucose, and fasting lipid will be performed before the meal test. At 9h30, subjects will be served 250g of durian or 417.6g of banana in a plate with 200 mL of water, and requested to consume the entire test meal within 10 min. Thermic effect of test meal will be performed after ingestion for 3 hours. Blood glucose fluctuation will be measured at 15 min, 30 min, 60 min, 90 min, 120 min, 180 min, and lipid fluctuation will be measured at 60 min, 120 min, and 180 min by finger prick. Blood pressure and heart rate readings will be taken at 30 min, 60 min, 120 min, 180 min.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 117599
- Clinical Nutrition Research Centre (CNRC)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- BMI with the range of 18-25 kg/m2
- Aged between 21 and 40 year-old
- Chinese origin
- Non-diabetic, fasting blood glucose ≤ 5.6 mmol/L
- Blood pressure below 140/90 mmHg
- Pass the general health screening questionnaire
- Have a stable bodyweight (<5%) over the past 6 months
- Have no medical history
- Have ability to provide informed consent
Exclusion Criteria:
- Subjects who are smoker or currently on nicotine therapy
- Subjects who regularly consume alcohol (>1 unit per day)
- Subjects who are currently receiving therapy (e.g. insulin) or any medication/treatment (including supplements) that may affect glucose and lipid metabolism, energy metabolism or body composition.
- Subjects who are currently on steroids, protease inhibitors, or antipsychotic therapies
- Subjects who recently had a major medical or surgical event or will have one during the study period
- Subjects who have symptomatic Irritable Bowel Syndrome
- Subjects who have glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Subjects who have active Tuberculosis (TB) or currently receiving treatment for TB
- Subjects who have chronic infection or is known to suffer from or has previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)
- Subjects who participated in drug trial within 3 months before the start of the study
- Subjects who have allergy or intolerant to durian or/and banana
- Subjects who are unwilling to consume durian or banana
- Subjects who are hemophobia, trypanophobia, or claustrophobia
- Subjects (females) who are pregnant (pregnancy test will be performed), lactating, or planning to become pregnant during the study period
- Subjects who do not have adequate fluency in the English language
- Subjects who are unable to understand the study procedures and to sign forms providing written informed consent to participate in the study
- Subjects who are a member of the research team or their immediate family members. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Durian
250 g of durian aril (isocaloric)
|
2 types of exotic fruits, durian and banana, are the study test meals.
Both isocaloric test meals are performed at breakfast.
All subjects are required to consume the entire meal within 10 minutes.
|
Other: Banana
417.6 g of banana (isocaloric)
|
2 types of exotic fruits, durian and banana, are the study test meals.
Both isocaloric test meals are performed at breakfast.
All subjects are required to consume the entire meal within 10 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thermic effect of food
Time Frame: 3 hours
|
Measured using the Indirect calorimetry (canopy hood)
|
3 hours
|
Blood Pressure
Time Frame: 5 timepoints at 0 minute, 30 minutes, 60 minutes, 120 minutes, and 180 minutes
|
Measured using an automated instrument (Omron HEM-907)
|
5 timepoints at 0 minute, 30 minutes, 60 minutes, 120 minutes, and 180 minutes
|
Heart Rate
Time Frame: 5 timepoints at 0 minute, 30 minutes, 60 minutes, 120 minutes, and 180 minutes
|
Measured using an automated instrument (Omron HEM-907)
|
5 timepoints at 0 minute, 30 minutes, 60 minutes, 120 minutes, and 180 minutes
|
Postprandial blood glucose levels
Time Frame: 7 timepoints at 0 minute, 15 minutes, 30 minutes, 60 minutes, 90 minutes, 120 minutes, and 180 minutes
|
Glucose levels will be measured using a portable glucose analyzer (Hemocue glucose 201 RT).
|
7 timepoints at 0 minute, 15 minutes, 30 minutes, 60 minutes, 90 minutes, 120 minutes, and 180 minutes
|
Postprandial lipid levels
Time Frame: 4 timepoints at 0 minute, 60 minutes, 120 minutes, and 180 minutes
|
Triglycerides, Cholesterol, LDL, HDL measured using the Cobas b101 system
|
4 timepoints at 0 minute, 60 minutes, 120 minutes, and 180 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: XinYan Bi, PhD, Senior Scientist II
Publications and helpful links
General Publications
- Ho LH, Bhat R. Exploring the potential nutraceutical values of durian (Durio zibethinus L.) - an exotic tropical fruit. Food Chem. 2015 Feb 1;168:80-9. doi: 10.1016/j.foodchem.2014.07.020. Epub 2014 Jul 11.
- Terada Y, Hosono T, Seki T, Ariga T, Ito S, Narukawa M, Watanabe T. Sulphur-containing compounds of durian activate the thermogenesis-inducing receptors TRPA1 and TRPV1. Food Chem. 2014 Aug 15;157:213-20. doi: 10.1016/j.foodchem.2014.02.031. Epub 2014 Feb 15.
- Zubairi, S.I., et al., Durian Locule (Endocarp) Water Immersion Drinking Effect to Reduce Heaty Sensation after Flesh Consumption: A Preliminary Study. Current Research in Nutrition and Food Science Journal, 2021. 9(3): p. 866-874.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2023-052
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
Istituto Auxologico ItalianoRecruitingArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
-
Swansea UniversityNational Taiwan Normal UniversityRecruitingBlood PressureTaiwan, United Kingdom
-
Columbia UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingBlood PressureUnited States
-
Yale UniversityPatient-Centered Outcomes Research InstituteRecruiting
-
University College, LondonNot yet recruiting
-
GE HealthcareRecruiting
Clinical Trials on Food/meal intervention
-
Virginia Polytechnic Institute and State UniversityRecruiting
-
Skidmore CollegeCompletedObesity | Weight Loss
-
Hvidovre University HospitalTerminatedCirrhosis | Esophageal VaricesDenmark
-
Skidmore CollegeCompleted
-
University of East AngliaPepsiCo Global R&D; Quadram Institute BioscienceUnknownBioavailabilityUnited Kingdom
-
University of LeedsCompletedObesity | OverweightUnited Kingdom
-
New York Obesity and Nutrition Research CenterColumbia University; St. Luke's-Roosevelt Hospital CenterUnknown
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNutrition, HealthyUnited States
-
Imperial College LondonNot yet recruitingHealthy Volunteers | Blood Glucose | Wearables | Metabolism | Energy Intake | Digestion | Dietary Intake AssessmentUnited Kingdom